Menopause Might Become Optional for Women
What: New tech and drugs like rapamycin aim to extend ovarian function.
Key Line: “You want to extend normal heart function… but slowing ovarian aging touches a very different note.”
Drew Altman breaks down the real-world consequences of Kennedy’s sweeping HHS overhaul.
Once academic, now viral—this disinfectant may be the most powerful skin-safe cleanser yet.
A class action lawsuit reveals dangerous conditions at one CPC, prompting ultrasound regulations.
New data shows fertilizing 7–9 eggs is ideal for live births and minimizing excess embryos.
DOJ says states can’t overrule FDA—even as future restrictions loom.
Study finds no mass OBGYN flight from states with abortion bans—yet.
An editorial calls for moving beyond reproductive-only focus in women’s health.
Cardiology experts warn cutting WHI would jeopardize sex-specific research advances.
Year-long birth control prescriptions could cut unintended pregnancies and save money, says R Street.
SWHR warns proposed Trump budget would slash NIH and CDC funding.
One-third of patients spend more than $50,000 on fertility treatments, according to a new survey.
Women under 50 are 40% less likely than men to get early transfusions after trauma.
Yale study shows women in Southern states barely gained life expectancy over 100 years.
Most menopause-marketed products are rebranded basics—at luxury prices, says Women’s Health investigation.
Luxury spa resort launches new “Inner Glow” retreat focused on hormone health and long-term wellness.
NIH insists WHI is funded, but federal contract officers haven’t been told.
Systemic hormones may worsen incontinence; local therapy helps, study says.
Trump administration floats baby bonuses, fertility funding, and fertility-focused Fulbrights.
Bladder-leak brand Poise proposes using pads for hormone testing in rural areas.
Women who start menopause before age 40 may face faster cognitive decline.